NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
SLPAX
Price
$13.85
Change
+$0.01 (+0.07%)
Updated
Jul 31 closing price
Net Assets
200.45M
Interact to see
Advertisement

NAESX vs SLPAX

NAESX vs SLPAX Comparison Chart in %
View a ticker or compare two or three
VS
NAESX vs. SLPAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a Hold and SLPAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. SLPAX (200M). SLPAX (1.11) and NAESX (1.10) have matching dividends . NAESX was incepted earlier than SLPAX: NAESX (66 years) vs SLPAX (30 years). SLPAX (0.72) is less costly to investors than NAESX (0.17). SLPAX is a more actively managed with annual turnover of: 90.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than SLPAX: NAESX (0) vs SLPAX (100000). NAESX annual gain was more profitable for investors over the last year : 22.56 vs. SLPAX (1.71). NAESX return over 5 years is better than : 34.95 vs. SLPAX (-19.64).
NAESXSLPAXNAESX / SLPAX
Total Expense Ratio0.170.4240%
Annual Report Gross Expense Ratio0.170.7224%
Fund Existence66 years30 years-
Gain YTD14.56315.48394%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets189B200M94,500%
Annual Yield % from dividends1.101.1199%
Returns for 1 year22.561.711,321%
Returns for 3 years43.3019.65220%
Returns for 5 years34.95-19.64-178%
Returns for 10 years155.28-6.91-2,248%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv